DRW Securities LLC Has $857,000 Stake in Danaher Co. (NYSE:DHR)

DRW Securities LLC grew its holdings in Danaher Co. (NYSE:DHR) by 100.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,081 shares of the conglomerate’s stock after purchasing an additional 1,541 shares during the quarter. DRW Securities LLC’s holdings in Danaher were worth $857,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently bought and sold shares of DHR. Mount Yale Investment Advisors LLC raised its position in shares of Danaher by 84.3% during the first quarter. Mount Yale Investment Advisors LLC now owns 1,836 shares of the conglomerate’s stock worth $459,000 after acquiring an additional 840 shares during the last quarter. Ascent Group LLC raised its position in shares of Danaher by 7.8% during the first quarter. Ascent Group LLC now owns 1,693 shares of the conglomerate’s stock worth $423,000 after acquiring an additional 123 shares during the last quarter. Waverly Advisors LLC raised its position in shares of Danaher by 251.1% during the first quarter. Waverly Advisors LLC now owns 8,774 shares of the conglomerate’s stock worth $2,191,000 after acquiring an additional 6,275 shares during the last quarter. Ancora Advisors LLC raised its position in shares of Danaher by 4.6% during the first quarter. Ancora Advisors LLC now owns 6,898 shares of the conglomerate’s stock worth $1,723,000 after acquiring an additional 305 shares during the last quarter. Finally, Tidal Investments LLC raised its position in shares of Danaher by 14.4% during the first quarter. Tidal Investments LLC now owns 52,421 shares of the conglomerate’s stock worth $13,089,000 after acquiring an additional 6,618 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Up 0.8 %

DHR stock opened at $237.65 on Tuesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The stock has a market capitalization of $171.65 billion, a P/E ratio of 45.35, a P/E/G ratio of 4.34 and a beta of 0.85. The business has a 50-day moving average of $257.38 and a 200-day moving average of $259.93. Danaher Co. has a fifty-two week low of $215.68 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. Danaher’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.02 earnings per share. On average, sell-side analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a yield of 0.45%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Analyst Ratings Changes

DHR has been the subject of a number of recent analyst reports. TD Cowen upped their price objective on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Wells Fargo & Company initiated coverage on Danaher in a report on Tuesday, August 27th. They issued an “equal weight” rating and a $280.00 price objective for the company. UBS Group dropped their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. Barclays dropped their price objective on Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a report on Wednesday, October 23rd. Finally, KeyCorp upped their price objective on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.